SPN and cancer: To validate the idea that CD43 expression favors the tumorigenic potential of human derived cancer cells, nude mice were injected subcutaneously with A549, CasKi or DLD-1 cells expressing normal or low CD43 levels (RNAi, CD43low) and the number of mice that developed a tumor as well as the tumor weight were evaluated.